Article info

Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP)

Authors

  1. Correspondence to Mr David Carcedo, Hygeia Consulting SL, Madrid, Spain; david.carcedo{at}hygeiaconsulting.com
View Full Text

Citation

Salas C, Martín-López J, Martínez-Pozo A, et al
Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP)

Publication history

  • Received November 23, 2020
  • Revised December 28, 2020
  • Accepted December 30, 2020
  • First published March 15, 2021.
Online issue publication 
February 17, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.